AOLS | Aeolus Pharmaceuticals, Inc. Annual & Quarterly

Annual Income Statements

(In USD)

Breakdown	2023	2022	2021	2020	2019	2016
Revenue	-	-	-	-	-	2.07 Million
Cost of Revenue	-	-	-	-	-	2.88 Million
Gross Profit	-	-	-	-	-	-805 Thousand
Operating Expenses	-	-	-	-	-	5.34 Million
Selling, General and Administrative Expenses	-	-	-	-	-	2.46 Million
Research and Development Expenses	-	-	-	-	-	2.88 Million
Other Expenses	-	-	-	-	-	-
Cost and Expenses	-	-	-	-	-	5.34 Million
Operating Income	-	-	-	-	-	-3.27 Million
Interest Expense	-	-	-	-	-	285 Thousand
Income Tax Expense	-	-	-	-	-	-3.27 Million
Earnings before Tax	-	-	-	-	-	-3.55 Million
Net Income	-	-	-	-	-	-3.55 Million
Earnings Per Share Basic	-	-	-	-	-	-0.02
Earnings Per Share Diluted	-	-	-	-	-	-0.02
Weighted Average Shares Outstanding	-	-	-	-	-	148.66 Million
Weighted Average Shares Outstanding (Diluted)	-	-	-	-	-	148.66 Million
Gross Margin	-	-	-	-	-	-0.39
EBIT Margin	-	-	-	-	-	-1.58
Profit Margin	-	-	-	-	-	-1.71
EBITDA	-	-	-	-	-	-3.27 Million
Earnings Before Tax Margin	-	-	-	-	-	-1.58

Breakdown	2023 FY	2022 FY	2021 FY	2020 FY	2019 FY	2017 Q3
Revenue	-	-	-	-	-	13 Thousand
Cost of Revenue	-	-	-	-	-	425 Thousand
Gross Profit	-	-	-	-	-	-412 Thousand
Operating Expenses	-	-	-	-	-	962 Thousand
Selling, General and Administrative Expenses	-	-	-	-	-	537 Thousand
Research and Development Expenses	-	-	-	-	-	425 Thousand
Other Expenses	-	-	-	-	-	-
Cost and Expenses	-	-	-	-	-	962 Thousand
Operating Income	-	-	-	-	-	-949 Thousand
Interest Expense	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-949 Thousand
Earnings before Tax	-	-	-	-	-	-949 Thousand
Net Income	-	-	-	-	-	-949 Thousand
Earnings Per Share Basic	-	-	-	-	-	-0.01
Earnings Per Share Diluted	-	-	-	-	-	-0.01
Weighted Average Shares Outstanding	-	-	-	-	-	152.08 Million
Weighted Average Shares Outstanding (Diluted)	-	-	-	-	-	152.08 Million
Gross Margin	-	-	-	-	-	-31.69
EBIT Margin	-	-	-	-	-	-73.00
Profit Margin	-	-	-	-	-	-73.00
EBITDA	-	-	-	-	-	-949 Thousand
Earnings Before Tax Margin	-	-	-	-	-	-73.00